1 Min Read
Sept 18 (Reuters) - IPSEN SA:
* U.S. FDA APPROVES NEW INDICATION FOR IPSEN’S SOMATULINE DEPOT (LANREOTIDE) INJECTION FOR THE TREATMENT OF CARCINOID SYNDROME Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.